A multimodal approach to cancer-related cachexia: from theory to practice

Alice Avancini,Ilaria Trestini,Daniela Tregnago,Massimo Lanza,Jessica Menis,Lorenzo Belluomini,Michele Milella,Sara Pilotto
DOI: https://doi.org/10.1080/14737140.2021.1927720
2021-05-27
Expert Review of Anticancer Therapy
Abstract:<span><b>Introduction</b>: Cachexia represents a relevant issue in oncological care, which is still lacking effective therapies. Although the incidence of cancer cachexia varies across cancer types, it is responsible for approximately a quarter of cancer-related deaths. The pathophysiology of this syndrome is multifactorial, including weight loss, muscle atrophy and impairment of the pro-/anti-inflammatory balance.<b>Areas covered</b>: Diagnostic criteria and optimal endpoints for cachexia-dedicated trials are still debated, slowing the identification of interventions counteracting cachexia <i>sequaele</i>. The multifaceted features of this syndrome support the rationale for personalized therapy. A multimodal approach is likely to offer the best option to address key cachexia-related issues. Pharmacologic agents, physical exercise, nutritional and psycho-social interventions may have a synergistic effect, and improve quality of life.<b>Expert opinion</b>: A personalized multimodal intervention could be the best strategy to effectively manage cancer cachexia. To offer such a comprehensive approach, a specialized staff, including health professionals with different expertise, is necessary. Each specialist plays a specific role inside the multimodal intervention, with the aim of delivering the best cancer care and access to the most effective therapeutic options for each patient.</span>
oncology
What problem does this paper attempt to address?